Biotechnology-derived products have the potential to bring tremendous positive changes to the society, from improving health care through new drugs and cures, increasing agricultural products to producing a cleaner environment. The public markets now recognize this potential, and a lot of money continues to flow into biotechnology companies.

Biotech industry in India at present is at the threshold of tremendous growth. India’s biotechnology sector showed 39 per cent growth last year to reach a value of $705 million, according to a report in India’s Financial Express newspaper, with biopharmaceuticals accounting for more than three quarters of the total.

The biotechnology sector is likely to generate annual revenues of $5 billion by 2010, according to a study by Ernst and Young. Biopharmaceuticals are expected to continue to constitute a major share of the growing market.

India's agricultural biotechnology industry has the necessary policy and regulatory support to promote research and development.

BFC offers its services to biotech ventures involving anti-infective drug research, one of the most promising areas of the global pharmaceutical business.

Other biotech areas benefiting the services could be development applications and biotech ventures developing path-breaking products ranging from tissue repair to anti-HIV drugs, drugs for infectious diseases like cancer and Alzheimer’s disease.

We are open to other Biotech areas as well and request you to submit the business plan to us.